Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study.

Autor: Samarakoon U; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts., Wolfson AR; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Zhou L; Harvard Medical School, Boston, Massachusetts; Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Bassir F; Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Phillips E; Department of Medicine, Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia., Kroshinsky D; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts., Cucka B; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts., Biglione B; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts., Phadke NA; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Jaggers J; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Byrne EC; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts., Judd AD; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts., Blumenthal KG; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: kblumenthal@mgh.harvard.edu.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Aug; Vol. 91 (2), pp. 370-373. Date of Electronic Publication: 2024 Apr 26.

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.

Autor: Haydu JE; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Maron JS; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA., Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Gallagher KME; Immune Monitoring Laboratory, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA; and., Fischinger S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA., Barnes JA; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Hochberg EP; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Johnson PC; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Takvorian RW; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Katsis K; Immune Monitoring Laboratory, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA; and., Portman D; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Ruiters J; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Sechio S; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Devlin M; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Regan C; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Blumenthal KG; Department of Allergy and Immunology., Banerji A; Department of Allergy and Immunology., Judd AD; Department of Allergy and Immunology., Scorsune KJ; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., McGree BM; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Sherburne MM; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Lynch JM; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Weitzman JI; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Lei M; Department of Pharmacy., Kotton CN; Department of Infectious Diseases, and., Dighe AS; Department of Pathology, Massachusetts General Hospital, Boston, MA., Maus MV; Immune Monitoring Laboratory, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA; and., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA., Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA., Soumerai JD; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.

Publikováno v: Blood advances [Blood Adv] 2022 Mar 22; Vol. 6 (6), pp. 1671-1683.